C12Y 306/01
In phosphorus-containing anhydrides
Official title: in phosphorus-containing anhydrides (3.6.1)
C12Y306/01 (In phosphorus-containing anhydrides) appears on 134 US grants and 265 published applications in this corpus.
Search patents in C12Y- Granted patents
- 134
- Published applications
- 265
- Assignees
- 167
- Inventors
- 606
- Latest grant
- 30 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 2 |
| 2003 | 0 | 2 |
| 2004 | 7 | 2 |
| 2005 | 2 | 2 |
| 2006 | 1 | 3 |
| 2007 | 0 | 2 |
| 2008 | 1 | 1 |
| 2009 | 1 | 3 |
| 2010 | 0 | 5 |
| 2011 | 1 | 4 |
| 2012 | 0 | 5 |
| 2013 | 7 | 8 |
| 2014 | 4 | 5 |
| 2015 | 1 | 14 |
| 2016 | 5 | 13 |
| 2017 | 4 | 19 |
| 2018 | 13 | 16 |
| 2019 | 11 | 11 |
| 2020 | 5 | 21 |
| 2021 | 16 | 17 |
| 2022 | 11 | 20 |
| 2023 | 13 | 22 |
| 2024 | 11 | 30 |
| 2025 | 7 | 24 |
| 2026 | 9 | 14 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12Y 306/01005Apyrase , i.e. atp diphosphohydrolase29
- C12Y 306/01009Nucleotide diphosphatase , i.e. nucleotide-pyrophosphatase28
- C12Y 306/01003Adenosine triphosphatase25
- C12Y 306/01015Nucleoside-triphosphatase9
- C12Y 306/01001Inorganic diphosphatase7
- C12Y 306/01029Bis-triphosphatase6
- C12Y 306/01045Udp-sugar diphosphatase5
- C12Y 306/01031Phosphoribosyl-atp diphosphatase3
All 49 subgroupsShow fewer
- C12Y 306/01039Thymidine-triphosphatase , i.e. t4 helicase3
- C12Y 306/01008Atp diphosphatase2
- C12Y 306/01017Bis-tetraphosphatase2
- C12Y 306/0103M7gpppn diphosphatase2
- C12Y 306/01054Udp-2,3-diacylglucosamine diphosphatase2
- C12Y 306/01006Nucleoside-diphosphatase1
- C12Y 306/01007Acylphosphatase1
- C12Y 306/01011Exopolyphosphatase1
- C12Y 306/01022Nad+ diphosphatase1
- C12Y 306/01023Dutp diphosphatase1
- C12Y 306/01026Cdp-diacylglycerol diphosphatase1
- C12Y 306/01027Undecaprenyl-diphosphate phosphatase1
- C12Y 306/01002Trimetaphosphatase0
- C12Y 306/0101Endopolyphosphatase0
- C12Y 306/01012Dctp diphosphatase0
- C12Y 306/01013Adp-ribose diphosphatase0
- C12Y 306/01014Adenosine-tetraphosphatase0
- C12Y 306/01016Cdp-glycerol diphosphatase0
- C12Y 306/01018Fad diphosphatase0
- C12Y 306/01019Nucleoside-triphosphate diphosphatase0
- C12Y 306/01025'-acylphosphoadenosine hydrolase0
- C12Y 306/01021Adp-sugar diphosphatase0
- C12Y 306/01024Nucleoside phosphoacylhydrolase0
- C12Y 306/01025Triphosphatase0
- C12Y 306/01028Thiamine-triphosphatase0
- C12Y 306/0104Guanosine-5'-triphosphate,3'-diphosphate diphosphatase0
- C12Y 306/01041Bis-tetraphosphatase0
- C12Y 306/01042Guanosine-diphosphatase0
- C12Y 306/01043Dolichyldiphosphatase0
- C12Y 306/01044Oligosaccharide-diphosphodolichol diphosphatase0
- C12Y 306/01052Diphosphoinositol-polyphosphate diphosphatase0
- C12Y 306/01053Mn2+-dependent adp-ribose/cdp-alcohol diphosphatase0
- C12Y 306/010558-oxo-dgtp diphosphatase0
- C12Y 306/010562-hydroxy-datp diphosphatase0
- C12Y 306/01057Udp-2,4-diacetamido-2,4,6-trideoxy-beta-l-altropyranose hydrolase0
- C12Y 306/010588-oxo-dgdp phosphatase0
- C12Y 306/01059M7gpppx diphosphatase0
- C12Y 306/0106Diadenosine hexaphosphate hydrolase0
- C12Y 306/01061Diadenosine hexaphosphate hydrolase0
- C12Y 306/01062M7gpppn-mrna hydrolase0
- C12Y 306/01063Alpha-d-ribose 1-methylphosphonate 5-triphosphate diphosphatase0
Recent patents
- Combination treatment by administering a recombinant apyrase protein in conjunction with a P2Y12 inhibitor30 Jun 2026US 12,668,785 B2AstraZeneca AB
- Cells, tissues, organs, and animals having one or more modified genes for enhanced xenograft survival and tolerance26 May 2026US 12,637,690 B2eGenesis, Inc.
- Cells, tissues, organs, and animals having one or more modified genes for enhanced xenograft survival and tolerance19 May 2026US 12,630,838 B2eGenesis, Inc.
- Compositions and methods for treating pathological calcification and ossification31 Mar 2026US 12,589,137 B2Yale University
- Use of HSP70 as a regulator of enzymatic activity17 Mar 2026US 12,576,076 B2Zevra Denmark A/S
- Methods of producing rna3 Sep 2026US 2026/0258464 A1ModernaTX, Inc.
- Novel porous carbonaceous material, process for the preparation thereof, and uses thereof13 Aug 2026US 2026/0234601 A1Centre National De La Recherche Scientifique
- Inkjet-assisted enzymatic nucleic acid synthesis6 Aug 2026US 2026/0226523 A1DNA Script
- An engineered rice with reduced vacuolar proton pyrophosphatase 5 (vpp5) expression30 Jul 2026US 2026/0218223 A1Board of Trustees of the University of Arkansas
- Relevant products and use of inorganic pyrophosphatase in synthesis of nucleotide strands23 Jul 2026US 2026/0209811 A1Hongene Biotech Pte. Ltd.
Most cited
By later US patents
- Combined use of .beta.-galactosidase and sialyltransferase coupled with in situ regeneration of CMP-sialic acid for one pot synthesis of oligosaccharides130US 5,374,541 ACytel Corporation · 1994
- Compositions and methods for treating pathological calcification and ossification23US 9,744,219 B2Yale University · 2017
- Method of treatment based on ATAD2 inhibitors22US 8,691,747 B2Glaxo Group Limited · 2014
- Method of determining the probability of a therapeutic response in cancer chemotherapy with cardiac glycoside16US 8,367,363 B2Phoenix Biotechnology, Inc. · 2013
- Compositions for treating pathological calcification conditions, and methods using same15US 10,064,917 B2Yale Unviersity · 2018